Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Do patients with neurocysticercosis benefit from cysticidal therapy?

Nature Clinical Practice Neurology volume 3, pages 22–23 (2007)Cite this article

boxed-textDel Brutto OH et al. (2006) Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 145: 43–51

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. White AC Jr (1997) Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 24: 101–115

    Article  PubMed  Google Scholar 

  2. Garcia HH and Del Brutto OH (2005) Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 4: 653–661

    Article  PubMed  Google Scholar 

  3. Carpio A and Hauser WA (2002) Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 59: 1730–1734

    Article  PubMed  Google Scholar 

  4. Salinas R and Prasad K (2000) Drugs for treating neurocysticercosis (tapeworm infection of the brain). The Cochrane Database of Systematic Reviews, Issue 2, Art. No CD000215.pub2

    Google Scholar 

  5. Garcia HH et al. (2004) A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350: 249–258

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Neurology Service, New Mexico Veterans Affairs Health Care System, 1501 San Pedro Drive, South East Albuquerque, NM 87108, USA ledavis@unm.edu

Authors and Affiliations

  1. LE Davis is Professor of Neurology at the University of New Mexico and Chief of the Neurology Service at the New Mexico Veterans Affairs Health Care System, Albuquerque, NM, USA.,

    Larry E Davis

Authors
  1. Larry E Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, L. Do patients with neurocysticercosis benefit from cysticidal therapy?. Nat Rev Neurol 3, 22–23 (2007). https://doi.org/10.1038/ncpneuro0378

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0378

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing